HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshihide Fujiyama Selected Research

Hepatitis C

7/2011Interleukin-28B polymorphisms are associated with an early viral response in patients receiving hepatitis C therapy.
9/2008Lower-Dose and Long-Term Intermittent Interferon Therapy for Hepatitis C Genotype 2a may be a Possibility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshihide Fujiyama Research Topics

Disease

31Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2013 - 04/2002
26Ulcerative Colitis
04/2013 - 01/2002
24Colitis
01/2013 - 01/2002
23Crohn Disease (Crohn's Disease)
04/2014 - 01/2003
14Neoplasms (Cancer)
07/2014 - 02/2002
14Inflammation (Inflammations)
11/2012 - 01/2002
7Infections
02/2019 - 03/2003
7Body Weight (Weight, Body)
06/2011 - 04/2002
5Carcinoma (Carcinomatosis)
07/2013 - 06/2003
5Pathologic Constriction (Stenosis)
02/2008 - 06/2005
5Pancreatitis
08/2005 - 01/2002
4Chronic Pancreatitis
12/2011 - 01/2003
4Ascites
01/2007 - 04/2002
3Hepatocellular Carcinoma (Hepatoma)
07/2014 - 07/2011
3Colorectal Neoplasms (Colorectal Cancer)
02/2014 - 06/2011
3Ulcer
02/2013 - 10/2003
3Adenoma (Adenomas)
12/2012 - 01/2008
3Esophageal Neoplasms (Esophageal Cancer)
06/2012 - 08/2007
3Gastroesophageal Reflux (GERD)
04/2012 - 01/2002
3Hemorrhage
06/2008 - 06/2002
3Esophageal Stenosis (Esophageal Stricture)
02/2008 - 01/2006
3Animal Diseases
10/2003 - 01/2002
2Acquired Immunodeficiency Syndrome (AIDS)
02/2019 - 05/2007
2Peritonitis
02/2019 - 01/2007
2Carcinogenesis
11/2013 - 08/2004
2Adenocarcinoma
11/2013 - 01/2008
2Stomach Neoplasms (Stomach Cancer)
11/2013 - 01/2007
2Chronic Hepatitis C
01/2012 - 09/2008
2Hepatitis C
07/2011 - 09/2008
2Fibrosis (Cirrhosis)
04/2010 - 07/2006
2Edema (Dropsy)
03/2010 - 11/2007
2Disease Progression
05/2007 - 06/2002
2Stroke (Strokes)
07/2003 - 07/2003

Drug/Important Bio-Agent (IBA)

18Dextran SulfateIBA
01/2013 - 04/2002
14Therapeutic UsesIBA
11/2012 - 01/2002
9Proteins (Proteins, Gene)FDA Link
01/2014 - 01/2002
8CytokinesIBA
09/2013 - 12/2004
7SteroidsIBA
07/2014 - 12/2008
7Volatile Fatty AcidsIBA
01/2011 - 01/2002
6Infliximab (Remicade)FDA Link
04/2014 - 01/2003
6AntibodiesIBA
01/2014 - 05/2002
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2013 - 07/2002
5Dextrans (Dextran)FDA Link
01/2013 - 01/2002
5sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2013 - 01/2002
5InterferonsIBA
01/2012 - 09/2008
5Messenger RNA (mRNA)IBA
10/2011 - 06/2003
5PrebioticsIBA
01/2011 - 01/2002
5Interleukin-6 (Interleukin 6)IBA
11/2004 - 01/2002
4Complement System Proteins (Complement)IBA
01/2013 - 02/2002
4InterleukinsIBA
05/2011 - 07/2002
4Butyrates (Butyrate)IBA
01/2011 - 01/2002
4Azathioprine (Imuran)FDA LinkGeneric
01/2011 - 01/2008
3LigandsIBA
02/2014 - 06/2011
3Polysaccharides (Glycans)IBA
02/2014 - 08/2004
3MucinsIBA
11/2013 - 03/2009
3DNA (Deoxyribonucleic Acid)IBA
07/2013 - 06/2003
3Peroxidase (Myeloperoxidase)IBA
01/2013 - 04/2002
3Tacrolimus (Prograf)FDA LinkGeneric
11/2012 - 01/2011
3Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2012 - 03/2010
3Bile Acids and Salts (Bile Acids)IBA
04/2012 - 11/2002
3Ribavirin (Virazole)FDA LinkGeneric
01/2012 - 07/2011
3Interleukin-33IBA
10/2011 - 04/2010
32-mercaptopurineIBA
09/2011 - 09/2008
3Immunosuppressive Agents (Immunosuppressants)IBA
01/2011 - 01/2008
3Dietary FiberFDA Link
02/2007 - 01/2003
3Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2003 - 04/2002
3IS 741IBA
01/2003 - 04/2002
2Interferon-gamma (Interferon, gamma)IBA
02/2019 - 01/2011
2Sorafenib (BAY 43-9006)FDA Link
07/2014 - 07/2013
2LectinsIBA
02/2014 - 10/2003
2Indicators and Reagents (Reagents)IBA
02/2014 - 12/2012
2Adalimumab (Humira)FDA Link
01/2014 - 02/2013
2Tumor Biomarkers (Tumor Markers)IBA
01/2014 - 06/2011
2Monoclonal AntibodiesIBA
11/2013 - 01/2004
2Prednisolone (Predate)FDA LinkGeneric
07/2013 - 10/2002
2Macrophage Migration-Inhibitory FactorsIBA
06/2012 - 01/2008
2Cell Adhesion MoleculesIBA
06/2011 - 01/2003
2DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
06/2011 - 05/2007
2Immunologic Factors (Immunomodulators)IBA
01/2011 - 05/2007
2Phenobarbital (Luminal)FDA Link
01/2011 - 06/2002
2AcidsIBA
01/2011 - 02/2006
2Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
01/2011 - 09/2008
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
04/2010 - 06/2003
2poly(lactide) (polylactic acid)IBA
02/2008 - 08/2007
2SolutionsIBA
01/2008 - 01/2003
2CausticsIBA
08/2007 - 01/2006
2Dietary Fats (Dietary Fat)IBA
11/2003 - 02/2003
2Glutamine (L-Glutamine)FDA Link
11/2003 - 01/2003
2Sulfonic AcidsIBA
11/2003 - 01/2003
2Free Radical ScavengersIBA
07/2003 - 07/2003
2AmylasesFDA Link
07/2003 - 04/2002

Therapy/Procedure

32Therapeutics
07/2014 - 10/2002
8Oral Administration
01/2011 - 01/2002
4Stents
06/2012 - 01/2006
2Drug Therapy (Chemotherapy)
01/2017 - 01/2007
2Surgical Instruments (Clip)
12/2012 - 08/2004
2Colectomy
07/2012 - 09/2005
2Enteral Nutrition (Feeding, Tube)
11/2007 - 01/2003
2Laparotomy
11/2007 - 04/2004
2Blood Component Removal (Apheresis)
08/2005 - 04/2005